NIH Press Advisory
NATIONAL INSTITUTES OF HEALTH
 National Cancer Institute
FOR IMMEDIATE RELEASE
Sunday, April 5, 1998

NCI Press Office
(301) 496-6641


Press Conference: New Findings From the Breast Cancer Prevention Trial

WHAT:
Scientists from the National Cancer Institute and the National Surgical Adjuvant Breast and Bowel Project will discuss new findings from the Breast Cancer Prevention Trial, the study of tamoxifen in women at increased risk of breast cancer. No data will be available before the press conference.

WHO:
Richard Klausner, M.D., director, National Cancer Institute
Norman Wolmark, M.D., chairperson, National Surgical Adjuvant Breast and Bowel Project
Bernard Fisher, M.D., scientific director, National Surgical Adjuvant Breast and Bowel Project
Joseph Costantino, Dr. P.H., associate director, Biostatistical Center, Surgical Adjuvant Breast and Bowel Project
Leslie Ford, M.D., associate director, Early Detection and Community Oncology Program, Division of Cancer Prevention, NCI
Harold Varmus, M.D., director, National Institutes of Health

WHEN:
Press conference: 1 p.m. EDT
Monday, April 6, 1998

WHERE:
First floor auditorium
Hubert Humphrey Bldg.
Department of Health and Human Services
200 Independence Ave., S.W.
Washington, D.C. 20201

Metro: Blue Line, Federal Center, S.W.